Today Viz.ai, an artificial intelligence care coordination company, shared the closing of its Series C funding round worth $71 million. Scale Venture Partners and Insight Partners led the financing ...

In the span of only about four years, Viz.ai has quickly racked up an impressive list of FDA permissions for its artificial intelligence algorithms designed to spot anomalies in emergency medical ...

New solution helps reduce false activations through real-time data sharing and team coordination SAN FRANCISCO, October 08, 2025--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection ...

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai today announced that it has raised $71 million in Series C funding, led by Scale Venture Partners and Insight Partners with participation from Greenoaks, Kleiner ...

Expanded footprint to 1,700 hospitals and healthcare systems cements leadership in AI-powered care coordination Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, ...

After an FDA clearance earlier this year for its artificial intelligence-powered program designed to spot dangerous aneurysms, Viz.ai has raised $100 million to continue expanding into other ...

Artificial intelligence care coordination company Viz.ai landed an FDA 510(k) clearance for its new algorithm designed to detect cerebral aneurysms. Dubbed Viz Aneurysm, the technology was designed to ...

Viz.ai’s strategic expansion into new oncology service line, enhances the company’s leadership in stroke care, cardiology, trauma, and radiology SAN FRANCISCO, May 28, 2025--(BUSINESS WIRE)--Viz.ai, ...

Viz.ai Expands into Lung Disease to Accelerate Diagnosis and Care for Patients New software will incorporate natural language processing (NLP) for more effective patient screening and follow-up Viz.ai ...

Honored for excellence and innovation in cardiovascular health diagnostics for Viz HCM module SAN FRANCISCO--(BUSINESS WIRE)-- Viz.ai, the leader in AI-powered disease detection and intelligent care ...

SAN FRANCISCO & TEL AVIV, Israel--(BUSINESS WIRE)--Viz.ai, the developer of the first synchronized healthcare software (Viz) using artificial intelligence (AI), today announced a $50 million Series B ...

SAN FRANCISCO--(BUSINESS WIRE)-- Viz.ai, the leading AI-powered disease detection and intelligent care coordination platform, announced today it is partnering with Hyperfine, Inc. (Nasdaq: HYPR), ...